Unraveling the Diabetes-Heart Disease Mystery: A Red Blood Cell Connection?
Diabetes and cardiovascular disease are a deadly duo, but why? The longer an individual battles type 2 diabetes, the more their heart health is at stake. This is the startling revelation from a study by Karolinska Institutet researchers, who have shed light on a potential culprit: red blood cells.
But here's the twist: it's not just about having diabetes; it's about how long you've lived with it. The study, published in the journal Disease, found that the risk of cardiovascular disease escalates with the duration of type 2 diabetes (T2D). This increased risk is linked to alterations in red blood cells, specifically a molecule that could serve as an early warning sign.
The American Heart Association recognizes diabetes as a critical risk factor for cardiovascular disease. People with T2D are more likely to develop and succumb to heart attacks, strokes, and heart failure than their non-diabetic counterparts. Even with treatment and controlled glucose levels, the risk remains elevated due to various additional risk factors, such as high blood pressure, abnormal cholesterol, obesity, and smoking.
The culprit behind this heightened risk? Endothelial dysfunction, which worsens with longer diabetes duration. But the exact mechanisms remain a puzzle.
In a previous study, researchers identified that red blood cells in individuals with T2D can impair endothelial function due to reduced microRNA (miRNA)-210-3p. This miRNA is a tiny regulator of gene expression, particularly in low-oxygen environments, and plays a crucial role in metabolism, oxidative stress, and blood vessel function.
And this is where it gets intriguing: the researchers delved deeper to see if the duration of diabetes affects this red blood cell-endothelial dysfunction connection. They studied mice with T2D of various ages and patients with either newly diagnosed or long-standing T2D. The results were eye-opening: red blood cells from older diabetic mice and long-term T2D patients caused endothelial dysfunction, while those from younger mice or recent T2D patients did not. This dysfunction was associated with lower miR-210-3p levels, higher oxidative stress, and increased glycerol-3-phosphate dehydrogenase 2 expression. Remarkably, restoring miR-210-3p reversed the dysfunction.
"The duration of diabetes is a critical factor," says Zhichao Zhou, associate professor at Karolinska Institutet and lead author. "Red blood cells become harmful to blood vessels only after several years of diabetes." This discovery suggests that disease duration is a key player in red blood cell-induced vascular damage and positions miR-210-3p as a potential biomarker for cardiovascular disease in diabetes patients.
But the story doesn't end there. The researchers are now exploring if this biomarker can be utilized in larger population studies. "Identifying high-risk patients before vascular damage occurs is key to preventing complications," adds Eftychia Kontidou, a doctoral student involved in the study.
This research opens a new chapter in understanding the complex relationship between diabetes and cardiovascular disease, offering hope for improved prevention strategies. But it also raises questions: Could this biomarker revolutionize diabetes management? How might it impact patient care and outcomes? The answers may lie in further exploration and discussion.
